Seabather's Eruption Follow-up
- Author: Clarence William Brown Jr, MD; Chief Editor: William D James, MD more...
Further Inpatient Care
Patients rarely demonstrate associated systemic symptomatology severe enough to require hospitalization. Even then, treatment is largely supportive and should include systemic corticosteroids.
Inpatient & Outpatient Medications
Topical corticosteroids in combination with oral antihistamines are used to relieve local symptoms. Systemic corticosteroids should be reserved for patients with a severe cutaneous eruption and pronounced systemic symptoms.
Deterrence/Prevention
Showering with the bathing suit off is the only significant protective measure against seabather's eruption. Length of shower time; timing of the shower; bathing suit style; shower water temperature; towel drying upon emerging from the seawater; and application of ointment, creams, or lotions have no preventative effect.
Complications
Because of the nature of the allergic hypersensitivity underlying the disease, patients are susceptible to recurrence upon reexposure. Reports have described exaggerated symptomatology in recurrent cases of seabather's eruption, and, for such individuals, avoiding seawater on affected beaches during seasonal peaks is best.
Prognosis
Cutaneous eruptions clear in 2 weeks, with or without therapy.
Patient Education
Educate patients about thimble jellyfish larvae during peak seasons in affected areas and the preventative role of showering with the bathing suit off following exposure to the seawater.
For patient education materials, see the Environmental Exposures and Injuries Center; Bites and Stings Center; and Jellyfish, Stingray, and Other Water Animal Bites/Stings Center, as well as Jellyfish Stings and Stingray Injury.
Segura Puertas L, Burnett JW, Heimer de la Cotera E. The medusa stage of the coronate scyphomedusa Linuche unguiculata ('thimble jellyfish') can cause seabather's eruption. Dermatology. 1999;198(2):171-2. [Medline].
Kumar S, Hlady WG, Malecki JM. Risk factors for seabather's eruption: a prospective cohort study. Public Health Rep. Jan-Feb 1997;112(1):59-62. [Medline].
Freudenthal AR, Joseph PR. Seabather's eruption. N Engl J Med. Aug 19 1993;329(8):542-4. [Medline].
Wong DE, Meinking TL, Rosen LB, Taplin D, Hogan DJ, Burnett JW. Seabather's eruption. Clinical, histologic, and immunologic features. J Am Acad Dermatol. Mar 1994;30(3):399-406. [Medline].
Bernhardt MJ, Mandojana RM. "Seabather's eruption". Clin Dermatol. Jul-Sep 1987;5(3):101-2. [Medline].
Burnett JW, Calton GJ, Burnett HW. Jellyfish envenomation syndromes. J Am Acad Dermatol. Jan 1986;14(1):100-6. [Medline].
Fisher AA. Toxic and allergic cutaneous reactions to jellyfish with special reference to delayed reactions. Cutis. Oct 1987;40(4):303-5. [Medline].
Kettle M. Americans adrift in an ocean of fears. The Guardian Weekly. February 8, 2001:Available at http://www.vuw.ac.nz/~caplabtb/dprk/adrift.html.
Letot B, Kharfi M, Mandojana R, Piérard GE. [Undesirable reactions from contact with marine organisms]. Rev Med Liege. Jun 2000;55(6):531-7. [Medline].
Mandojana RM, Letot B. Historical outlook of aquatic biotoxicology and balneology as related to dermatology. Classification of aquatic dermatoses. Clin Dermatol. Jul-Sep 1987;5(3):1-7. [Medline].
Mandojana RM, Sims JK. Miscellaneous dermatoses associated with the aquatic environment. Clin Dermatol. Jul-Sep 1987;5(3):134-45. [Medline].

